Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy

References

• Angelopoulou A, Kolokithas-Ntoukas A, Fytas C, et al. (2019). Folic acid-functionalized, condensed magnetic nanoparticles for targeted delivery of doxorubicin to tumor cancer cells overexpressing the folate receptor. ACS Omega 4:22214–27.
   PubMed Web of Science ®Google Scholar
• Bagheri S, Yasemi M, Safaie-Qamsari E, et al. (2018). Using gold nanoparticles in diagnosis and treatment of melanoma cancer, Artificial cells, nanomedicine. Artif Cells Nanomed Biotechnol 46:462–71.
   PubMed Web of Science ®Google Scholar
• Benyettou F, Das G, Nair A, et al. (2020). Covalent organic framework embedded with magnetic nanoparticles for MRI and chemo-thermotherapy. J Am Chem Soc 142:18782–94.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang W, Sun C, et al. (2020). Systemic nanoparticle-mediated delivery of pantetheinase vanin-1 regulates lipolysis and adiposity in abdominal white adipose tissue. Adv Sci (Weinh) 7:2000542.
   PubMedGoogle Scholar
• Cheng X, Li D, Sun M, et al. (2019). Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer. Colloids Surf B Biointerfaces 181:185–97.
   PubMed Web of Science ®Google Scholar
• Ci T, Li H, Chen G, et al. (2020). Cryo-shocked cancer cells for targeted drug delivery and vaccination. Sci Adv 6:eabc3013.
   PubMed Web of Science ®Google Scholar
• Cullen J, Simmons J, Parsons P, et al. (2020). Topical treatments for skin cancer. Adv Drug Deliv Rev 153:54–64.
   PubMed Web of Science ®Google Scholar
• Da Silva CG, Camps MGM, Li T, et al. (2019). Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines. Biomaterials 220:119417.
   PubMed Web of Science ®Google Scholar
• Dafni U, Michielin O, Lluesma S, et al. (2019). Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis. Ann Oncol 30:1902–13.
   PubMed Web of Science ®Google Scholar
• Fu J, Li T, Yang Y, et al. (2021). Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors. Biomaterials 268:120537.
   PubMed Web of Science ®Google Scholar
• Hasani-Sadrabadi M, Majedi F, Miller M, et al. (2020). Augmenting T-cell responses to tumors by in situ nanomanufacturing. Mater Horiz 7:3028–33.
   PubMed Web of Science ®Google Scholar
• He J, Li C, Ding L, et al. (2019). Tumor targeting strategies of smart fluorescent nanoparticles and their applications in cancer diagnosis and treatment. Adv Mater 31:e1902409.
   PubMed Web of Science ®Google Scholar
• Hu C, He X, Chen Y, et al. (2021). Metformin mediated PD‐L1 downregulation in combination with photodynamic‐immunotherapy for treatment of breast cancer. Adv Funct Mater 2020:2007149.
   PubMed Web of Science ®Google Scholar
• Hu X, Yang F, Liao Y, et al. (2017). Cholesterol-PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations. Drug Deliv 24:121–32.
   PubMed Web of Science ®Google Scholar
• Huang K, Boerhan R, Liu C, et al. (2017). Nanoparticles penetrate into the multicellular spheroid-on-chip: effect of surface charge, protein corona, and exterior flow. Mol Pharm 14:4618–27.
   PubMed Web of Science ®Google Scholar
• Islam MA, Xu Y, Tao W, et al. (2018). Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nat Biomed Eng 2:850–64.
   PubMed Web of Science ®Google Scholar
• Jain R, Stylianopoulos T. (2010). Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7:653–64.
   PubMed Web of Science ®Google Scholar
• Kang B, Okwieka P, Schottler S, et al. (2015). Carbohydrate-based nanocarriers exhibiting specific cell targeting with minimum influence from the protein corona. Angew Chem Int Ed Engl 54:7436–40.
   PubMed Web of Science ®Google Scholar
• Karki R, Sharma BR, Lee E, et al. (2020). Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight 5(12):e136720.
   PubMed Web of Science ®Google Scholar
• Kim S, Roszik J, Cho S, et al. (2019). The COX2 effector microsomal PGE2 synthase 1 is a regulator of immunosuppression in cutaneous melanoma. Clin Cancer Res 25:1650–63.
   PubMed Web of Science ®Google Scholar
• Kuang Y, Zhang Y, Zhao Y, et al. (2020). Dual-stimuli-responsive multifunctional Gd2Hf2O7 nanoparticles for MRI-guided combined chemo-/photothermal-/radiotherapy of resistant tumors. ACS Appl Mater Interfaces 12:35928–39.
   PubMed Web of Science ®Google Scholar
• Kumar Giri T, Giri A, Kumar Barman T, et al. (2016). Nanoliposome is a promising carrier of protein and peptide biomolecule for the treatment of cancer. Anticancer Agents Med Chem 16:816–31.
   PubMed Web of Science ®Google Scholar
• Li Y, Hou H, Zhang P, et al. (2020). Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy. Drug Deliv 27:1044–53.
   PubMed Web of Science ®Google Scholar
• Li Y, Luo J, Lin MT, et al. (2019). Co-delivery of metformin enhances the antimultidrug resistant tumor effect of doxorubicin by improving hypoxic tumor microenvironment. Mol Pharm 16:2966–79.
   PubMedGoogle Scholar
• Ling X, Jiang X, Li Y, et al. (2021). Sequential treatment of bioresponsive nanoparticles elicits antiangiogenesis and apoptosis and synergizes with a CD40 agonist for antitumor immunity. ACS Nano 15:765–80.
   PubMed Web of Science ®Google Scholar
• Liu S, Li W, Gai S, et al. (2019). A smart tumor microenvironment responsive nanoplatform based on upconversion nanoparticles for efficient multimodal imaging guided therapy. Biomater Sci 7:951–62.
   PubMed Web of Science ®Google Scholar
• Miller KD, Fidler-Benaoudia M, Keegan TH, et al. (2020). Cancer statistics for adolescents and young adults, 2020. CA A Cancer J Clin 70:443–59.
   PubMed Web of Science ®Google Scholar
• Mohamed J, Alqahtani A, Ahmad F, et al. (2021). Pectin co-functionalized dual layered solid lipid nanoparticle made by soluble curcumin for the targeted potential treatment of colorectal cancer. Carbohydr Polym 252:117180.
   PubMed Web of Science ®Google Scholar
• Musalli A, Talukdar P, Roy P, et al. (2020). Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma. Carbohydr Polym 244:116488.
   PubMed Web of Science ®Google Scholar
• Nakajima T, Kadowaki S, Minashi K, et al. (2020). Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer. Clin Cancer Res 27(4):3559.
   PubMed Web of Science ®Google Scholar
• Oh H, Lee J, Sung D, et al. (2020). Potential antioxidant and wound healing effect of nano-liposol with high loading amount of astaxanthin. Int J Nanomedicine 15:9231–40.
   PubMed Web of Science ®Google Scholar
• Palanikumar L, Al-Hosani S, Kalmouni M, et al. (2020). pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics. Commun Biol 3:95.
   PubMed Web of Science ®Google Scholar
• Rogalla S, Flisikowski K, Gorpas D, et al. (2019). Biodegradable fluorescent nanoparticles for endoscopic detection of colorectal carcinogenesis. Adv Funct Mater 29:1904992.
   PubMed Web of Science ®Google Scholar
• Saha K, Rahimi M, Yazdani M, et al. (2016). Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano 10:4421–30.
   PubMed Web of Science ®Google Scholar
• Sharma A, Burridge P, McKeithan W, et al. (2017). High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Sci Transl Med 9:eaaf2584.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. (2020). Cancer statistics, 2020. CA A Cancer J Clin 70:7–30.
   PubMed Web of Science ®Google Scholar
• Song M, Li L, Zhang Y, et al. (2017). Carboxymethyl-β-cyclodextrin grafted chitosan nanoparticles as oral delivery carrier of protein drugs. React Funct Polym 117:10–5.
   Web of Science ®Google Scholar
• Sun R, Liu Y, Li S, et al. (2020). Corrigendum to "Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells" [Biomaterials 37 (2015) 405-414]. Biomaterials 263:120373.
   PubMed Web of Science ®Google Scholar
• Tang J, Hou X, Yang C, et al. (2017). Recent developments in nanomedicine for melanoma treatment. Int J Cancer 141:646–53.
   PubMed Web of Science ®Google Scholar
• Tee J, Yip L, Tan E, et al. (2019). Nanoparticles' interactions with vasculature in diseases. Chem Soc Rev 48:5381–407.
   PubMed Web of Science ®Google Scholar
• Turner MC, Andersen ZJ, Baccarelli A, et al. (2020). Outdoor air pollution and cancer: an overview of the current evidence and public health recommendations. CA Cancer J Clin 70:460–479.
   Web of Science ®Google Scholar
• Wang C, Shi X, Song H, et al. (2020b). Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumor immunity against melanoma. Biomaterials 268:120579.
   PubMed Web of Science ®Google Scholar
• Wang G, Lin F, Wan Q, et al. (2020a). Mechanisms of action of metformin and its regulatory effect on microRNAs related to angiogenesis. Pharmacol Res 164:105390.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang M, Zheng M, et al. (2015). Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery. Colloids Surf B Biointerfaces 129:63–70.
   PubMed Web of Science ®Google Scholar
• Wang Z, Song L, Liu Q, et al. (2020c). A Tubular DNA nanodevice as a siRNA/chemo-drug co-delivery vehicle for combined cancer therapy. Angew Chem Int Ed Engl 60:2594–8.
   PubMed Web of Science ®Google Scholar
• Wei Z, Wang H, Xin G, et al. (2020). A pH-sensitive prodrug nanocarrier based on diosgenin for doxorubicin delivery to efficiently inhibit tumor metastasis. Int J Nanomedicine 15:6545–60.
   PubMed Web of Science ®Google Scholar
• Xiao W, Gao H. (2018). The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system. Int J Pharm 552:328–39.
   PubMed Web of Science ®Google Scholar
• Xiao W, Xiong J, Zhang S, et al. (2018). Influence of ligands property and particle size of gold nanoparticles on the protein adsorption and corresponding targeting ability. Int J Pharm 538:105–11.
   PubMed Web of Science ®Google Scholar
• Yang X, Hu C, Tong F, et al. (2019). Tumor microenvironment‐responsive dual drug dimer‐loaded pegylated bilirubin nanoparticles for improved drug delivery and enhanced immune‐chemotherapy of breast cancer. Adv Funct Mater 29:1901896.
   Web of Science ®Google Scholar
• York AW, Zablocki KR, Lewis DR, et al. (2012). Kinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacy. Adv Mater 24:733–9.
   PubMed Web of Science ®Google Scholar
• Zhang W, Dong Z, Xu M, et al. (2020). SWI/SNF complex subunit BAF60a represses hepatic ureagenesis through a crosstalk between YB-1 and PGC-1α. Mol Metab 32:85–96.
   PubMed Web of Science ®Google Scholar
• Zhang W, Shao W, Dong Z, et al. (2019). Cloxiquine, a traditional antituberculosis agent, suppresses the growth and metastasis of melanoma cells through activation of PPARγ. Cell Death Dis 10:404.
   PubMed Web of Science ®Google Scholar
• Zheng D, Pan P, Chen K, et al. (2020). An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure. Nat Biomed Eng 4:853–62.
   PubMed Web of Science ®Google Scholar
• Zheng Y, You X, Guan S, et al. (2019). Poly(ferulic acid) with an anticancer effect as a drug nanocarrier for enhanced colon cancer therapy. Adv Funct Mater 29:1808646.
   Web of Science ®Google Scholar